Ken Griffin’s Citadel flagship hedge fund returns 8% in September during market sell-off

Finance

Ken Griffin, Founder and CEO, Citadel
Mike Blake | Reuters

The volatile September was a golden opportunity for billionaire investor Ken Griffin to shine as his main hedge fund crushed the market with outperformance.

Citadel’s multi-strategy flagship fund Wellington gained 7.8% in September, bringing its year-to-date performance to 18.5%, according to a person familiar with the returns.

All five of the investment strategies of the fund — equities, commodities, global fixed income and macro, credit, and quantitative strategies — all registered gains last month, the person said.

The overall stock market suffered a roller-coaster ride in September as inflation fears, slowing growth and rising rates kept investors on edge. The S&P 500 fell 4.8% last month, posting its worst month since March 2020 and breaking a seven-month winning streak. The blue-chip Dow and the Nasdaq Composite dropped 4.3% and 5.3%, respectively, suffering their worst months of the year.

The hedge fund industry has been attracting new capital this year as the return of volatility sent investors to alternative assets. Hedge funds saw another $12 billion inflows in August, bringing the overall aseets under management to a record $3.622 trillion, according to data from eVestment.

Citadel’s other multi-strategy fund Tactical Trading gained 3.9% in September and is up 14.1% this year.

The hedge fund community gained about 10% in 2021 through the end of August, according to HFR. Citadel’s returns were first reported by Business Insider.

Enjoyed this article?
For exclusive stock picks, investment ideas and CNBC global livestream
Sign up for CNBC Pro
Start your free trial now

Articles You May Like

IRS to send 1 million taxpayers up to $1,400 in ‘special payments.’ How to know if you’re eligible
Treasury delays deadline for small businesses to file new form to avoid risk of fines for noncompliance
Trump’s 25% tariff could be an existential threat to Canada’s recovering auto industry
Lego is reinventing its iconic brick sets and keeping the toy industry afloat
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.

Leave a Reply

Your email address will not be published. Required fields are marked *